📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Syntaxin

1.1 - Company Overview

Syntaxin Logo

Syntaxin

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of bacterial-based protein therapeutics for neurological, inflammatory and endocrine diseases, leveraging a proprietary technology platform to engineer bacterial proteins via domain substitution.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Syntaxin

Spotlight Innovation Logo

Spotlight Innovation

HQ: United States Website
  • Description: Provider of support for commercializing healthcare technologies developed in America's powerhouse academic laboratories, including acquisition and development of medical sector intellectual property; patented Crotoxin administration for IV treatment of pain and neurologic or neuromuscular disorders; FDA-registered EPISORB using cardiotoxin as a cell-penetrating peptide; and cancer and pain therapeutics via Celtic Biotech Iowa.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Spotlight Innovation company profile →
Allegro Ophthalmics Logo

Allegro Ophthalmics

HQ: United States Website
  • Description: Provider of integrin inhibition therapy focused on retinal diseases, including Risuteganib (Luminate), an investigational compound targeting mitochondrial dysfunction and oxidative stress to restore retinal homeostasis for intermediate dry age-related macular degeneration, and ALG-1007, a topical mitochondrial stabilizer in development for dry eye disease with promising clinical trial results.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allegro Ophthalmics company profile →
Matrx Pharmaceuticals Logo

Matrx Pharmaceuticals

HQ: Poland Website
  • Description: Provider of pharmaceuticals.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Matrx Pharmaceuticals company profile →
Glycotope Logo

Glycotope

HQ: Germany Website
  • Description: Provider of GMP-compliant contract manufacturing for active biopharmaceutical ingredients (proteins and antibodies) via recombinant production, and oncology antibody solutions including GT-001 (Lewis Y), GT-002 (LYPD3), GT-00A (MUC1) and an IL-15 immuno-cytokine, plus GlycoTarget Discovery and a platform enabling high tumor-specificity by targeting tumor-associated carbohydrates for ADC/CAR development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Glycotope company profile →
VivaBioCell Logo

VivaBioCell

HQ: Italy Website
  • Description: Provider of innovative products leveraging proprietary cell culture and tissue engineering technologies for early diagnosis of autoimmune diseases (e.g., scleroderma, graft-versus-host disease) and treatment of oro-dental and maxillo-facial defects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full VivaBioCell company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Syntaxin

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Syntaxin

2.2 - Growth funds investing in similar companies to Syntaxin

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Syntaxin

4.2 - Public trading comparable groups for Syntaxin

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Syntaxin

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Syntaxin

What does Syntaxin do?

Syntaxin is a provider of bacterial-based protein therapeutics for neurological, inflammatory and endocrine diseases, leveraging a proprietary technology platform to engineer bacterial proteins via domain substitution.

Who are Syntaxin's competitors?

Syntaxin's competitors and similar companies include Spotlight Innovation, Allegro Ophthalmics, Matrx Pharmaceuticals, Glycotope, and VivaBioCell.

Where is Syntaxin headquartered?

Syntaxin is headquartered in United Kingdom.

How many employees does Syntaxin have?

Syntaxin has 1,000 employees 🔒.

When was Syntaxin founded?

Syntaxin was founded in 2010 🔒.

What sector and industry vertical is Syntaxin in?

Syntaxin is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Syntaxin

Who are the top strategic acquirers in Syntaxin's sector and industry

Top strategic M&A buyers and acquirers in Syntaxin's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Syntaxin?

Top strategic M&A buyers groups and sectors for Syntaxin include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Syntaxin's sector and industry vertical

Which are the top PE firms investing in Syntaxin's sector and industry vertical?

Top PE firms investing in Syntaxin's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Syntaxin's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Syntaxin's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Syntaxin's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Syntaxin include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Syntaxin's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Syntaxin?

The key public trading comparables and valuation benchmarks for Syntaxin include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Syntaxin for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Syntaxin with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Syntaxin's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Syntaxin with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Syntaxin's' sector and industry vertical?

Access recent funding rounds and capital raises in Syntaxin's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Syntaxin